A transmembrane polymorphism in FcγRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA

Genes and Immunity

Volumn 9, Issue 8, 2008, Pages 680-688

  Chen, J Y ^a   Wang, C M ^a   Ma, C C ^a   Hsu, L A ^a   Ho, H H ^a   Wu, Y J J ^a   Kuo, S N ^a   Wu, J ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC RECEPTOR IIB; ISOLEUCINE; MEMBRANE PROTEIN; THREONINE; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; FC RECEPTOR; FCGR2B PROTEIN, HUMAN; RHEUMATOID FACTOR;

ADULT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; JOINT DESTRUCTION; LIPID RAFT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; ADOLESCENT; AGE; AGED; ALLELE; BLOOD; CHILD; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; RHEUMATOID FACTOR; SEX FACTORS; TAIWAN; YOUNG ADULT;

EID: 57249111888     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.56     Document Type: Article

References (63)

1. Klareskog L, Padyukov L, Ronnelid J, Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006; 18: 650-655.
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-37.
3. Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, Danoy P et al Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001; 194: 321-330.
4. Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K et al Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet 2005; 14: 2305-2321.
5. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C et al. Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003; 48: 906-916.
6. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C et al New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-10750.
7. Salmon JE, Pricop L. Human receptors for immunoglobulin G: Key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; 44: 739-750.
8. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-1070.
9. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 1994; 368: 70-73.
10. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001; 19: 275-290.
11. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290: 84-89.
12. Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 2007; 8: 419-429.
13. Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005; 23: 503-514.
14. El Shikh ME, El Sayed R, Szakal AK, Tew JG. Follicular dendritic cell (FDC)-FcgammaRIIB engagement via immune complexes induces the activated FDC phenotype associated with secondary follicle development. Eur J Immunol 2006; 36: 2715-2724.
15. Qin D, Wu J, Vora KA, Ravetch JV, Szakal AK, Manser T et al. Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J Immunol 2000; 164: 6268-6275.
16. Tew JG, Wu J, Fakher M, Szakal AK, Qin D. Follicular dendritic cells: beyond the necessity of T-cell help. Trends Immunol 2001; 22 361-367.
17. Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003; 48: 3242-3252.
18. Kono H, Kyogoku C, Suzuki T, Tsuchiya N, Honda H, Yamamoto K et al Fc{gamma}RIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 2005; 14: 2881-2892.
19. Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, Macary PA, Rankin A et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005; 11: 1056-1058.
20. Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP et al. Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients. Arthritis Rheum 2006; 54: 3908-3917.
21. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-163.
22. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum 2004; 50: 709-715.
23. Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006; 65: 453-458.
24. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-361.
25. Cohen-Solal JF, Cassard L, Fridman WH, Sautes-Fridman C. Fc gamma receptors. Immunol Lett 2004; 92: 199-205.
26. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in Fc gamma RIIdeficient mice. Nature 1996; 379: 346-349.
27. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000; 13: 277-285.
28. Nakamura A, Yuasa T, Ujike A, Ono M, Nukiwa T, Ravetch JV et al. Fcgamma receptor IIB-deficient mice develop Good pasture's syndrome upon immunization with type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000; 191: 899-906.
29. Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 2000; 10: 227-230.
30. Yuasa T, Kubo S, Yoshino T, Ujike A, Matsumura K, Ono M et al. Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999; 189: 187-194.
31. Jiang Y, Hirose S, Abe M, Sanokawa-Akakura R, Ohtsuji M, Mi X et al Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000; 51: 429-435.
32. Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med 2000; 191: 1611-1616.
33. Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002; 46: 1242-1254.
34. Siriboonrit U, Tsuchiya N, Sirikong M, Kyogoku C, Bejrachandra S, Suthipinittharm P et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 2003; 61: 374-383.
35. Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: A common susceptibility gene in the Asian populations. Tissue Antigens 2004; 63: 21-27.
36. Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing Fcgamma RIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004; 172: 7186-7191.
37. Blank MC, Stefanescu RN, Masuda E, Marti F, King PD, Redecha PB et al Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 2005; 117: 220-227.
38. Aydar Y, Sukumar S, Szakal AK, Tew JG. The influence of immune complex-bearing follicular dendritic cells on the IgM response, Ig class switching, and production of high affinity IgG. J Immunol 2005; 174: 5358-5366.
39. Aydar Y, Balogh P, Tew JG, Szakal AK. Altered regulation of Fc gamma RII on aged follicular dendritic cells correlate with immunoreceptor tyrosine-based inhibition motif signaling in B cells and reduced germinal center formation. J Immunol 2003; 171: 5975-5987.
40. Aydar Y, Wu J, Song J, Szakal AK, Tew JG. Fcgamma RII expression on follicular dendritic cells and immunoreceptor tyrosine-based inhibition motif signaling in B cells. Eur J Immunol 2004; 34: 98-107.
41. Yada A, Ebihara S, Matsumura K, Endo S, Maeda T, Nakamura A et al. Accelerated antigen presentation and elicitation of humoral response in vivo by Fcgamma RIIB- and Fcgamma RI/III-mediated immune complex uptake. Cell Immunol 2003; 225: 21-32.
42. Rao SP, Vora KA, Manser T. Differential expression of the inhibitory IgG Fc receptor Fcgamma RIIB on germinal center cells: Implications for selection of high-affinity B cells. J Immunol 2002; 169: 1859-1868.
43. Zusman T, Gohar O, Eliassi H, Avivi Y, Lisansky E, Sautes C et al. The murine Fc-gamma (Fc gamma) receptor type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells. Int J Cancer 1996; 65: 221-229.
44. Callanan MB, Le Baccon P, Mossuz P, Duley S, Bastard C, Hamoudi R et al. The IgG Fc receptor, Fcgamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Proc Natl Acad Sci USA 2000; 97: 309-314.
45. O'Garra A, Rigley KP, Holman M, McLaughlin JB, Klaus GG. B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation. Proc Natl Acad Sci USA 1987; 84: 6254-6258.
46. Rudge EU, Cutler AJ, Pritchard NR, Smith KG. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J Exp Med 2002; 195: 1079-1085.
47. Radstake TR, Franke B, Wenink MH, Nabbe KC, Coenen MJ, Welsing P et al. The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis. Arthritis Rheum 2006; 54: 3828-3837.
48. Barrow AD, Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: The ambiguity of immunoreceptor signalling. Eur J Immunol 2006; 36: 1646-1653.
49. Magnusson SE, Engstrom M, Jacob U, Ulfgren AK, Kleinau S. High synovial expression of the inhibitory Fcgamma RIIb in rheumatoid arthritis. Arthritis Res Ther 2007; 9: R51.
50. Radstake TR, Blom AB, Sloetjes AW, van Gorselen EO, Pesman GJ, Engelen L et al. Increased Fcgamma RII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1556-1563.
51. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/ 0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset, and disease severity. J Rheumatol 1995; 22 1032-1036.
52. Jawaheer D, Lum RF, Gregersen PK, Criswell LA. Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum 2006; 54: 3087-3094.
53. Kastbom A, Ahmadi A, Soderkvist P, Skogh T. The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: Increased susceptibility and severity in male patients (the Swedish TIRA project). Rheumatology (Oxford) 2005; 44: 1294-1298.
54. Kyogoku C, Tsuchiya N, Matsuta K, Tokunaga K. Studies on the association of Fc gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: Evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes Immun 2002; 3: 488-493.
55. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113-2121.
56. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52 3433-3438.
57. van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 2007; 56: 425-432.
58. Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 2007; 9: R56.
59. Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52: 3813-3818.
60. Sigurdsson S, Padyukov L, Kurreeman FA, Liljedahl U, Wiman AC, Alfredsson L et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007; 56: 2202-2210.
61. Magnusson V, Zunec R, Odeberg J, Sturfelt G, Truedsson L, Gunnarsson I et al. Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis Rheum 2004; 50: 1348-1350.
62. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
63. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1949; 140: 659-662.